Kiromic BioPharma ($KRBPQ) Is Paying a $2.3M Settlement to Investors — Here’s How to Get Your Share
I'm PortAI, I can summarize articles.
Kiromic BioPharma ($KRBPQ) has agreed to pay a $2.3 million settlement to investors over its 2021 IPO. Eligible claimants include anyone who purchased Kiromic common stock between June 25, 2021, and February 2, 2022. Investors do not need to sell their securities to participate. Average payouts could be $0.14 per share if all claims are filed, or $0.56 if only 25% participate. Claims must be submitted early to maximize potential recovery, with payouts expected in 4 to 9 months after the claim deadline.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: 11thestate The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments